Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience

Annals of Indian Academy of Neurology

Volumn 16, Issue 3, 2013, Pages 376-379

  Unni, Narayanan ^a   Barhate, Kavita ^b   Ahmad, Nisha ^c   Ganeshan, Malti ^b   Singhal, Bhim ^b  

^a Department of Neurology   (India)

^b BOMBAY HOSPITAL   (India)

^c Metropolis Health Services (India) Pvt Ltd   (India)

Author keywords

Anti aquaporin 4 seropositivity; neuromyelitis optica; neuromyelitis optica Immunoglobulin G seropositivity; transverse myelitis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; DEMYELINATING DISEASE; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; INDIA; INDIAN; LONGITUDINALLY EXTENSIVE TRANSVERSE MYELITIS; MALE; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROMYELITIS OPTICA IGG TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SATISFACTION; RETROSPECTIVE STUDY;

EID: 84883720254     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.116945     Document Type: Article

References (19)

1. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004;364:2106-12. (Pubitemid 39626806)
2. Wingerchuk DM, Lennon VA, Pittock SJ, Luchinetti CF, Weinshenker BG. Revised diagnostic criteria for Neuromyelitis optica. Neurology 2006;66:1485-9. (Pubitemid 43958540)
3. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I. Nakamura M, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: A study on antibody titre. Brain 2007;130:1235-43. (Pubitemid 47355956)
4. Jain S, Maheshwari MC. Multiple sclerosis: Indian experience in the last thirty years. Neuroepidemiology 1985;4:96-107. (Pubitemid 16213741)
5. Waters PJ, McKeon A, Leite Ml, Rajasekharan S, Lennon VA, Villalobos A, et al. Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-lgG assays. Neurology 2012;78:665-71.
6. Kuroiwa Y. Neuromyelitis optica. Demyelinating diseases. In: Vinken PJ, Bruyn GW, Klawans HL, editors. Handbook of Clinical Neurology. Vol. 3. Amsterdam: Elsevier Science Publishers; 1985. p. 397-408.
7. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-14. (Pubitemid 29442132)
8. Singhal BS. Clinical profile and HLA-studies in Indian multiple sclerosis patients from the Bombay region. In: Kuroiwa Y. Kurland LT, editors. Multiple Sclerosis East and West. Japan: Kyushu University Press; 1982. p. 123-34.
9. Weinshenker BG. Neuromyelitis optica in western countries: Establishing diagnostic criteria and characterization of the spectrum. Neurol Asia 2008;13:161-6.
10. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005;202:473-7. (Pubitemid 41186945)
11. Lana-Peixoto MA. Devic's neuromyelitis optica: A critical review. Arq Neuropsiquiatr 2008;66:120-38. (Pubitemid 351520737)
12. Jacob A. Neuromyelitis optica-an update: 2007-2009. Ann Indian Acad Neurol 2009;12:231-7.
13. Jacob A, Matiello M, Wingerchuk DM, Lucchinetti CF, Pittock SJ, Weinshenker BG. Neuromyelitis optica: Changing concepts. J Neuroimmunol 2007;187:126-38. (Pubitemid 47007701)
14. Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J, etal. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 2007;68:1076-7. (Pubitemid 46569147)
15. Adoni T, Lino AM, MarchioriPE, Kok F, Callegaro D. Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica. Arq Neuropsiquiatr 2008;66:295-7. (Pubitemid 352030269)
16. Pandit L. Neuromyelitis optica antibody (NMO-IgG) status in Indian patients with multiple sclerosis and allied demyelinating disorders. Neurol Asia 2008;13:175-8.
17. Jarius S, Paul F, Franciotta D, Aktas O, Hohlfeld R, Zipp F, etal. Revised diagnostic criteria for neuromyelitis optica: Incorporation of NMO-IgG status. Nat Clin Pract Neurol 2007;3:e1.
18. Kira J. Neuromyelitis optica and asian phenotype of multiple sclerosis. Ann N Y Acad Sci 2008;1142:58-71.
19. Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation 2012;9:14-31.